Cala Health
Series C in 2024
Cala Health, Inc. is a bioelectronic medicine company based in Burlingame, California, founded in 2013. It specializes in developing wearable neuromodulation therapies aimed at treating chronic diseases. The company's flagship product, Cala Trio, is a non-invasive prescription therapy designed to provide transient relief from hand tremors in adults with essential tremor. By integrating advancements in neuroscience and technology, Cala Health focuses on delivering individualized peripheral nerve stimulation. In addition to its work on essential tremor, the company is also developing therapies for other neurological conditions, including Parkinson's disease, as well as applications in psychiatry, cardiology, and autoimmune disorders.
Signos is focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through an innovative approach that combines continuous glucose monitoring with an AI-powered application. The company's platform offers real-time insights and personalized recommendations aimed at facilitating sustainable weight loss. By utilizing a wearable device alongside its software, Signos allows users to monitor their glucose levels and visualize their metabolism, empowering them to make informed dietary choices. With a significant portion of the American population facing challenges related to weight management, Signos provides a novel solution to help individuals understand their unique physiological responses to food, ultimately supporting their journey toward a healthier lifestyle.
TeknTrash
Seed Round in 2022
TeknTrash is AI+analytics company which provides companies with consumer data To that end it developed Stipra: a software which manages consumption data for companies to understand consumer patterns Stipra is comprised of a SAAS cloud based portal, an APP, and a network of SmartPODs ("Point of Disposal") able to capture consumption data, reward users, and provide real consumption data and analytics
Signos is focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through an innovative approach that combines continuous glucose monitoring with an AI-powered application. The company's platform offers real-time insights and personalized recommendations aimed at facilitating sustainable weight loss. By utilizing a wearable device alongside its software, Signos allows users to monitor their glucose levels and visualize their metabolism, empowering them to make informed dietary choices. With a significant portion of the American population facing challenges related to weight management, Signos provides a novel solution to help individuals understand their unique physiological responses to food, ultimately supporting their journey toward a healthier lifestyle.
OneNav specializes in developing a mobile positioning system tailored for smartphones, wearables, and Internet of Things (IoT) tracking devices. The company's innovative system leverages the modernized L5 signaling band from navigation satellite constellations, enhancing the accuracy and reliability of position data. By incorporating artificial intelligence, OneNav provides clients with upgraded, data-rich signals that support various tracking applications, ensuring precise location services across multiple platforms.
BlueSemi
Seed Round in 2020
BlueSemi is a revolution in connected customer-centric Health Tech. A company on a mission to bring a positive transformation into people’s lives by making holistic wellness an integral part of their life with their one-of-a-kind innovation. They leverage the fourth wave of technology including Artificial Intelligence and the Internet of Things to bring their vision into reality. Based out of India, BlueSemi is determined at blending together health, wellness, & cutting-edge technology to create a virtual world where people look up to explore, analyze, and optimize their lifestyle through real-time interactions, and with utmost comfort that makes self-care easy, interesting, and fun. They've built EYVA, the world's first non-invasive gadget to give 6 key vitals including non-invasive (no prick/no blood) Blood Glucose, ECG, Heart Rate, Spo2, HbA1c & Blood Pressure by a touch in just 60 seconds along with a whole new world, Anthea Realm where people can improve their lifestyles.
Element Science
Series C in 2020
Element Science, Inc. is a medical device and digital health company focused on developing solutions for high-risk cardiovascular patients. The company's flagship product is a patch-based wearable cardioverter defibrillator that continuously monitors heart activity to protect against sudden cardiac death. This device integrates advanced data science and machine learning algorithms with strict electromechanical medical device standards, creating a proprietary digital platform that enhances patient care as individuals transition from hospital to home. Founded in 2011 and headquartered in San Francisco, California, Element Science aims to address critical health needs and reduce hospitalization rates associated with heart disease. The company was previously known as Revive Defibrillation Systems, Inc. before adopting its current name in 2014.
Fitbit
Acquisition in 2019
Fitbit is a company focused on promoting healthier lifestyles through its digital health and fitness devices. It develops the Fitbit Tracker, a compact wireless wearable sensor that automatically monitors various aspects of a user's activities, including calories burned, sleep quality, steps taken, and distance traveled. This device continuously collects data while worn throughout the day, which is then wirelessly uploaded to a dedicated website. Users can access their information to track progress toward personal health goals, engage with a motivational interface, and share achievements with friends, family, and co-workers. Additionally, the platform allows users to manually log nutrition, weight, and other health metrics, providing a comprehensive overview of their well-being. By automating health data collection and offering an engaging user experience, Fitbit aims to simplify the journey toward a healthier lifestyle.
Cala Health
Series C in 2019
Cala Health, Inc. is a bioelectronic medicine company based in Burlingame, California, founded in 2013. It specializes in developing wearable neuromodulation therapies aimed at treating chronic diseases. The company's flagship product, Cala Trio, is a non-invasive prescription therapy designed to provide transient relief from hand tremors in adults with essential tremor. By integrating advancements in neuroscience and technology, Cala Health focuses on delivering individualized peripheral nerve stimulation. In addition to its work on essential tremor, the company is also developing therapies for other neurological conditions, including Parkinson's disease, as well as applications in psychiatry, cardiology, and autoimmune disorders.
CTRL-Labs
Venture Round in 2019
CTRL-Labs Corporation, founded in 2015 and based in New York City, specializes in developing non-invasive neural interface technology aimed at enhancing the interaction between humans and machines. The company's flagship product, the CTRL-kit, is a wireless wristband equipped with sensors that captures neural signals, allowing users to control digital devices through simple electronic pulses. This innovative platform is designed to support various applications in virtual reality, augmented reality, robotics, productivity, and clinical research. By providing developers with a software development kit (SDK) and application programming interface (API), CTRL-Labs enables the integration of neural control into their applications. The company's long-term vision focuses on fostering mass consumer adoption of neural interfaces, establishing a new standard for human-machine collaboration that transforms how users engage with technology.
CTRL-Labs
Series B in 2018
CTRL-Labs Corporation, founded in 2015 and based in New York City, specializes in developing non-invasive neural interface technology aimed at enhancing the interaction between humans and machines. The company's flagship product, the CTRL-kit, is a wireless wristband equipped with sensors that captures neural signals, allowing users to control digital devices through simple electronic pulses. This innovative platform is designed to support various applications in virtual reality, augmented reality, robotics, productivity, and clinical research. By providing developers with a software development kit (SDK) and application programming interface (API), CTRL-Labs enables the integration of neural control into their applications. The company's long-term vision focuses on fostering mass consumer adoption of neural interfaces, establishing a new standard for human-machine collaboration that transforms how users engage with technology.
Cronologics
Acquisition in 2016
Cronologics Corporation, based in San Mateo, California, is a startup focused on advancing wearable technology. The company has created an Android-based software platform designed specifically for smartwatches, aiming to simplify the development of engaging hardware and software experiences. With a team comprised of professionals from renowned organizations such as Google, MIT Media Lab, Motorola, and Facebook, Cronologics addresses complex challenges in the industry. The company collaborates with both startups and established technology firms, as well as key players in the lifestyle, fashion, and fitness sectors, to foster the widespread adoption of wearable technology.
Element Science
Series B in 2016
Element Science, Inc. is a medical device and digital health company focused on developing solutions for high-risk cardiovascular patients. The company's flagship product is a patch-based wearable cardioverter defibrillator that continuously monitors heart activity to protect against sudden cardiac death. This device integrates advanced data science and machine learning algorithms with strict electromechanical medical device standards, creating a proprietary digital platform that enhances patient care as individuals transition from hospital to home. Founded in 2011 and headquartered in San Francisco, California, Element Science aims to address critical health needs and reduce hospitalization rates associated with heart disease. The company was previously known as Revive Defibrillation Systems, Inc. before adopting its current name in 2014.
Cala Health
Series B in 2016
Cala Health, Inc. is a bioelectronic medicine company based in Burlingame, California, founded in 2013. It specializes in developing wearable neuromodulation therapies aimed at treating chronic diseases. The company's flagship product, Cala Trio, is a non-invasive prescription therapy designed to provide transient relief from hand tremors in adults with essential tremor. By integrating advancements in neuroscience and technology, Cala Health focuses on delivering individualized peripheral nerve stimulation. In addition to its work on essential tremor, the company is also developing therapies for other neurological conditions, including Parkinson's disease, as well as applications in psychiatry, cardiology, and autoimmune disorders.
Element Science
Series A in 2014
Element Science, Inc. is a medical device and digital health company focused on developing solutions for high-risk cardiovascular patients. The company's flagship product is a patch-based wearable cardioverter defibrillator that continuously monitors heart activity to protect against sudden cardiac death. This device integrates advanced data science and machine learning algorithms with strict electromechanical medical device standards, creating a proprietary digital platform that enhances patient care as individuals transition from hospital to home. Founded in 2011 and headquartered in San Francisco, California, Element Science aims to address critical health needs and reduce hospitalization rates associated with heart disease. The company was previously known as Revive Defibrillation Systems, Inc. before adopting its current name in 2014.
Wimm Labs
Acquisition in 2013
WIMM Labs specializes in wearable technology, providing an open platform that supports modular hardware and Android-based Micro Apps. The company enables its licensee partners to develop innovative software and accessories for wearable devices, facilitating the deployment of these applications through its Micro App Store. By offering a comprehensive ecosystem for connected devices, WIMM Labs encourages collaboration among developers to enhance the functionality and user experience of wearable technology.
Pocket, the premier Save for Later app, lets you consume and share content whenever you want, wherever you want, even without an internet connection. It's been called "a DVR for the web" by the New York Times, Business Week, Time, TechCrunch and more. When you come across an article, video or a webpage you'd like to read but can't at that time, save it to Pocket. You can then read or watch it whenever you have a moment, whether it's on the couch, during your commute, on the plane, train, or practically anywhere. Millions of users save articles, videos, travel guides, recipes, how-to and reference documents, and more on Pocket, automatically syncing in a stunning and simple interface across devices like iPad, iPhone, Android, desktop and mobile web, Kobo e-reader, Chrome apps, Kindle Fire and now wearable devices like the Samsung Gear.
Pocket, the premier Save for Later app, lets you consume and share content whenever you want, wherever you want, even without an internet connection. It's been called "a DVR for the web" by the New York Times, Business Week, Time, TechCrunch and more. When you come across an article, video or a webpage you'd like to read but can't at that time, save it to Pocket. You can then read or watch it whenever you have a moment, whether it's on the couch, during your commute, on the plane, train, or practically anywhere. Millions of users save articles, videos, travel guides, recipes, how-to and reference documents, and more on Pocket, automatically syncing in a stunning and simple interface across devices like iPad, iPhone, Android, desktop and mobile web, Kobo e-reader, Chrome apps, Kindle Fire and now wearable devices like the Samsung Gear.
Collaborate.com
Seed Round in 2011
Collaborate.com offers a cloud-based team collaboration platform designed for the mobile workforce, integrating document sharing, task management, and communication into a single application accessible on iPhone, Android, and the Web. Founded in 2011 by entrepreneurs Matt Cutler and David Greenstein, the platform allows teams to quickly begin collaborating by leveraging its compatibility with popular cloud services such as Box, Dropbox, Evernote, Google Drive, and Apple iCloud. Users can access Collaborate.com via its website or by downloading the app from the App Store or Google Play. The company is based in Boston and supported by various investors, including Google Ventures and others.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.